Hep27scFv

has tumoricidal activity against the HCC-S102 (hepatocellular carcinoma cell line) as its parental antibody (Hep27 Mab); this scFv may be a potential candidate for a targeting agent in HCC immunodiagnosis or immunotherapy

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Fukui, Kiichi: 1 article (08/2005)
2.	Kurokawa, Yoichi: 1 article (08/2005)
3.	Sandee, Duanpen: 1 article (08/2005)
4.	Takagi, Masahiro: 1 article (08/2005)
5.	Tungpradabkul, Sumalee: 1 article (08/2005)

Related Diseases

1.	Hepatocellular Carcinoma (Hepatoma) 08/20/2005 - "In this study, we described the system for soluble expression of a single-chain variable fragment (scFv) against hepatocellular carcinoma (Hep27scFv) by coexpressing Dsb protein and enhancing with medium additives. "

Related Drugs and Biologics

1.	Single-Chain Antibodies
2.	Proteins (Proteins, Gene)
3.	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)